GenieMD Telehealth
By GenieMD
GenieMD Telehealth is a white-labeled virtual care platform for health systems and employers, offering video visits, secure messaging, and AI-driven triage on iOS and Android.
The App DNA
What makes this app unique?
The platform removes the technical and regulatory burden of building custom telehealth infrastructure, allowing medical groups to launch branded care services with integrated billing workflows.
For Healthcare organizations, hospitals, and employers seeking white-labeled telehealth and chronic care management infrastructure.
What does it look like?
Key features
Automated symptom triage and guidance system that flags whether a patient requires a video visit or prescription; automates patient intake to reduce operational overhead.
Customizable virtual care solution for hospitals and health systems; generates recurring revenue through enterprise licensing.
Remote patient monitoring and therapeutic monitoring programs with cellular device integration; enables CMS-compliant billing workflows.
How much does it cost?
The platform functions as a B2B enterprise solution with no public consumer pricing tiers.
Velocity
Maintenance developmentperformanceUX improvementsShow more...
With only two releases identified in the analyzed window and a total of 15 days since the latest update, the development momentum is categorized as maintenance. The latest release focuses exclusively on performance, stability, and general reliability improvements. There is a notable disparity in platform support, with the Android version receiving updates significantly more frequently than the iOS version, which has remained unchanged for 175 days. Development remains focused on technical upkeep rather than new feature delivery.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for GenieMD Telehealth
How's the Medical market?
GenieMD Telehealth occupies a niche B2B infrastructure role, prioritizing enterprise licensing over consumer chart performance. The absence of public ratings on Android confirms the platform's focus on closed-system deployment rather than public app store discovery.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for GenieMD Telehealth
Where is it heading?
The telehealth market is consolidating around integrated care platforms that handle both clinical and administrative workflows. GenieMD Telehealth is well-positioned to serve this trend by focusing on the billing and triage mechanisms that health systems struggle to build internally, ensuring the platform remains a sticky utility for its B2B partners.
- The maintenance-only release cadence suggests a focus on platform stability rather than aggressive feature expansion, which aligns with enterprise-grade B2B requirements.
- The focus on CMS-compliant billing workflows creates a high switching cost for medical groups, which secures long-term retention despite the lack of consumer-facing updates.
The SWOT
- AI-driven triage reduces operational overhead for B2B partners
- CMS-compliant billing workflows unlock direct revenue for medical groups
- High-value longevity and preventive health programs expand revenue per patient
- Employer-sponsored health programs provide a scalable B2B distribution channel
Next best moves
Audit AI triage accuracy because it is the core B2B differentiator → maintain enterprise trust
+ 1 more prioritized moveThe counter-intuitive read
The lack of consumer-facing brand traction is an advantage…
Read the full takeBottom line
GenieMD Telehealth maintains a stable B2B infrastructure position, but the lack of consumer-facing momentum suggests the platform relies entirely on enterprise sales cycles. Prioritizing the expansion of high-value longevity services would differentiate the platform from standard virtual visit providers.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] Developer website, source
- [2] App Store
- [3] Play Store
Report last updated